MX2010004337A - Estabilizacion de suspensiones oleosas que contienen acidos silicicos hidrofobos. - Google Patents
Estabilizacion de suspensiones oleosas que contienen acidos silicicos hidrofobos.Info
- Publication number
- MX2010004337A MX2010004337A MX2010004337A MX2010004337A MX2010004337A MX 2010004337 A MX2010004337 A MX 2010004337A MX 2010004337 A MX2010004337 A MX 2010004337A MX 2010004337 A MX2010004337 A MX 2010004337A MX 2010004337 A MX2010004337 A MX 2010004337A
- Authority
- MX
- Mexico
- Prior art keywords
- stabilisation
- suspensions containing
- oily suspensions
- silicic acids
- hydrophobic silicic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Fats And Perfumes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención se refiere a la estabilización de suspensiones fluidas a base de aceite que contienen un ácido silícico hidrófobo, así como a medicamentos a base de tales suspensiones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007055341A DE102007055341A1 (de) | 2007-11-19 | 2007-11-19 | Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren |
PCT/EP2008/009526 WO2009065514A1 (de) | 2007-11-19 | 2008-11-12 | Stabilisierung öliger suspensionen enthaltend hydrophobe kieselsäuren |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004337A true MX2010004337A (es) | 2010-07-30 |
Family
ID=40451435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004337A MX2010004337A (es) | 2007-11-19 | 2008-11-12 | Estabilizacion de suspensiones oleosas que contienen acidos silicicos hidrofobos. |
Country Status (15)
Country | Link |
---|---|
US (1) | US9095511B2 (es) |
EP (1) | EP2222338B1 (es) |
JP (1) | JP2011503217A (es) |
KR (2) | KR20100089080A (es) |
CN (1) | CN101861169B (es) |
AR (1) | AR069371A1 (es) |
AU (1) | AU2008328225B2 (es) |
BR (1) | BRPI0820624A2 (es) |
CA (1) | CA2705988C (es) |
DE (1) | DE102007055341A1 (es) |
HK (1) | HK1149477A1 (es) |
MX (1) | MX2010004337A (es) |
NZ (1) | NZ585397A (es) |
WO (1) | WO2009065514A1 (es) |
ZA (1) | ZA201002943B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20141031A1 (es) * | 2011-06-28 | 2014-08-21 | Bayer Healthcare Llc | Composicion farmaceutica oftalmologica topica que contiene regorafenib |
WO2013129944A1 (en) * | 2012-02-27 | 2013-09-06 | Bayer New Zealand Limited | Controlled release compositions and their methods of use |
DE102018122533A1 (de) * | 2018-09-14 | 2020-03-19 | Institut Dr. Rilling Healthcare Gmbh | Brenn- und essbare Zusammensetzung aus mittelkettigen Trigliceriden und Kieselsäure |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3996355A (en) | 1975-01-02 | 1976-12-07 | American Home Products Corporation | Permanent suspension pharmaceutical dosage form |
JPS5746986A (en) | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
US4670444B1 (en) | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
US4472405A (en) | 1982-11-12 | 1984-09-18 | Riker Laboratories, Inc. | Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives |
US4730000A (en) | 1984-04-09 | 1988-03-08 | Abbott Laboratories | Quinoline antibacterial compounds |
AT392789B (de) | 1985-01-23 | 1991-06-10 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten |
JPH0657653B2 (ja) * | 1985-08-23 | 1994-08-03 | 藤沢薬品工業株式会社 | 油性懸濁型直腸注入剤 |
IN166416B (es) | 1985-09-18 | 1990-05-05 | Pfizer | |
IL87483A (en) * | 1987-09-14 | 1993-07-08 | Abbott Lab | Anhydrous oil-based liquid suspension for delivering clorazepate dipotassium or estazolam |
JP2817146B2 (ja) | 1987-09-25 | 1998-10-27 | 藤沢薬品工業株式会社 | 油性直腸注入剤 |
JP3091913B2 (ja) * | 1990-07-18 | 2000-09-25 | エーザイ株式会社 | 光安定化したユビデカレノン含有組成物及びその製造方法 |
US5260341A (en) | 1992-07-14 | 1993-11-09 | Agro-K Corporation Inc. | Product and process for treating bovine mastitis and bovine metritis |
JP3448780B2 (ja) * | 1993-03-09 | 2003-09-22 | 積水化学工業株式会社 | ニトログリセリン貼付剤 |
JP3446309B2 (ja) * | 1994-06-20 | 2003-09-16 | 日本油脂株式会社 | 油性懸濁組成物およびその用途 |
IT1275955B1 (it) * | 1995-03-22 | 1997-10-24 | Dompe Spa | Formulazioni farmaceutiche in forma di gel tissotropico |
FR2739558B1 (fr) * | 1995-10-05 | 1997-11-28 | Innothera Lab Sa | Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale |
RU2173318C2 (ru) | 1996-02-23 | 2001-09-10 | Байер Акциенгезелльшафт | 8-циан-1-циклопропил-7-(2,8-диазабицикло(4.3.0)-нонан-8-ил)-6-фтор-1,4-дигидро-4-оксо-3-хинолинкарбоновые кислоты, их производные и фармацевтическая композиция, обладающая антибактериальной активностью |
FR2781373B1 (fr) * | 1998-07-07 | 2001-09-21 | Pf Medicament | Formulations thixotropes pour le remplissage de gelules |
DE60034770T2 (de) * | 1999-02-26 | 2008-04-30 | Sanofi-Aventis | Stabile fumagillin-formulierung |
FR2790200B3 (fr) | 1999-02-26 | 2001-06-01 | Sanofi Sa | Formulation stable contenant de la fumagilline |
AU4917900A (en) | 1999-05-07 | 2000-11-21 | Pharmasol Gmbh | Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
US6617356B2 (en) | 2000-01-03 | 2003-09-09 | Naturally Scientific Inc | Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements |
US20030039668A1 (en) * | 2001-03-08 | 2003-02-27 | Neo Tech Development Company, L.L.C. | Trans dermal skin care |
ITMI20011363A1 (it) | 2001-06-28 | 2002-12-28 | Enichem Spa | Procedimento per l'attivazione di catalizzatori zeolitici contenenti titanio e loro impiego nelle reazioni di ossidazione |
ATE385785T1 (de) | 2001-09-10 | 2008-03-15 | Hoffmann La Roche | Ölige thixotrope zusammensetzungen |
WO2003063877A1 (en) | 2002-02-01 | 2003-08-07 | Akzo Nobel N.V. | Cefquinome composition for intra-mammary administration in cattle |
US6602490B1 (en) * | 2002-03-04 | 2003-08-05 | Richard A. Cloonan | Dental cleaning formulation and manufacturing process |
CZ294371B6 (cs) * | 2002-06-10 | 2004-12-15 | Pliva - Lachema, A. S. | Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy |
DE10337191A1 (de) * | 2003-08-13 | 2005-03-17 | Bayer Healthcare Ag | Neue Verwendung von Chinolon-Antibiotika |
TR200301553A1 (tr) | 2003-09-18 | 2005-10-21 | Nobel �La� Sanay�� Ve T�Caret A.�. | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |
DE102004001558A1 (de) | 2004-01-10 | 2005-08-18 | Bayer Healthcare Ag | Arzneimittel zur topischen Applikation bei Tieren |
JP4077421B2 (ja) | 2004-03-31 | 2008-04-16 | 株式会社ムラコシ精工 | 部材保持装置 |
WO2006008640A1 (en) | 2004-07-15 | 2006-01-26 | Pharmacia & Upjohn Company Llc | Non-aqueous suspension containing a drug having an unpleasant taste |
MX2007006908A (es) | 2004-12-09 | 2007-08-03 | Bayer Healthcare Ag | Estabilizacion de esteres de glucocorticoides con acidos. |
DE102005055385A1 (de) | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
-
2007
- 2007-11-19 DE DE102007055341A patent/DE102007055341A1/de not_active Withdrawn
-
2008
- 2008-11-12 WO PCT/EP2008/009526 patent/WO2009065514A1/de active Application Filing
- 2008-11-12 EP EP08852496.2A patent/EP2222338B1/de not_active Not-in-force
- 2008-11-12 US US12/739,873 patent/US9095511B2/en not_active Expired - Fee Related
- 2008-11-12 JP JP2010534397A patent/JP2011503217A/ja active Pending
- 2008-11-12 NZ NZ585397A patent/NZ585397A/xx not_active IP Right Cessation
- 2008-11-12 CN CN2008801166469A patent/CN101861169B/zh not_active Expired - Fee Related
- 2008-11-12 MX MX2010004337A patent/MX2010004337A/es unknown
- 2008-11-12 AU AU2008328225A patent/AU2008328225B2/en not_active Ceased
- 2008-11-12 CA CA2705988A patent/CA2705988C/en not_active Expired - Fee Related
- 2008-11-12 BR BRPI0820624-4A patent/BRPI0820624A2/pt not_active IP Right Cessation
- 2008-11-12 KR KR1020107010668A patent/KR20100089080A/ko active IP Right Grant
- 2008-11-19 AR ARP080105030A patent/AR069371A1/es unknown
-
2010
- 2010-04-28 ZA ZA2010/02943A patent/ZA201002943B/en unknown
-
2011
- 2011-04-06 HK HK11103483.5A patent/HK1149477A1/xx not_active IP Right Cessation
-
2016
- 2016-02-23 KR KR1020160021213A patent/KR20160026960A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE102007055341A1 (de) | 2009-05-20 |
CA2705988A1 (en) | 2009-05-28 |
NZ585397A (en) | 2012-08-31 |
AU2008328225A1 (en) | 2009-05-28 |
AU2008328225B2 (en) | 2015-01-22 |
US9095511B2 (en) | 2015-08-04 |
US20100261688A1 (en) | 2010-10-14 |
BRPI0820624A2 (pt) | 2015-06-16 |
AR069371A1 (es) | 2010-01-20 |
ZA201002943B (en) | 2011-10-26 |
WO2009065514A1 (de) | 2009-05-28 |
CA2705988C (en) | 2017-10-24 |
JP2011503217A (ja) | 2011-01-27 |
KR20100089080A (ko) | 2010-08-11 |
CN101861169B (zh) | 2012-09-26 |
HK1149477A1 (en) | 2011-10-07 |
EP2222338B1 (de) | 2016-12-21 |
EP2222338A1 (de) | 2010-09-01 |
CN101861169A (zh) | 2010-10-13 |
KR20160026960A (ko) | 2016-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010103374A8 (en) | Oily suspension containing probiotic bacteria for paediatric uses | |
GB2426557B (en) | Severable piston pump | |
WO2009077443A3 (de) | Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel | |
MX2007012956A (es) | Uso de polimeros de polialquilmetacrilato. | |
WO2011079176A3 (en) | Microfluidic systems and methods for reducing the exchange of molecules between droplets | |
WO2009077497A3 (de) | Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel | |
EP2334800A4 (en) | MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL | |
WO2009077500A3 (de) | Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel | |
DK1871181T3 (da) | Kosttilskud til HIV-patienter | |
RS20100095A (en) | Bottle closure and assembly of such closure and bottle | |
WO2011033064A3 (en) | Disulfo-type fluorescent whitening agent compositions | |
WO2010033509A3 (en) | 14-hydroxy-docosahexaenoic acid compounds | |
AP2283A (en) | Stable aqueous suspension. | |
JP2011229212A5 (es) | ||
MX2010008668A (es) | Composiciones fungicidas que comprenden 3'-bromo-2,3,4,6'-tetramet oxy-2'-6-dimetilbenzofenona. | |
MX2010004337A (es) | Estabilizacion de suspensiones oleosas que contienen acidos silicicos hidrofobos. | |
EP2370558A4 (en) | LUBRICANTS WITH ALKYL-CYCLOHEXYL-1,2-DICARBOXYLATES | |
JP2010162333A5 (es) | ||
CA119996S (en) | Bottle | |
UA96476C2 (ru) | Фармацевтические композиции, которые содержат ирбесартан | |
JP2010215587A5 (es) | ||
JP2008299329A5 (es) | ||
JP2010133918A5 (es) | ||
EP2090745A4 (en) | FLUID EQUIPMENT | |
JP2011161465A5 (es) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assignment |